
Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orl​éans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orl​éans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
OBJ Insider FLASH SALE: Save 40% on Individual Subscriptions – July 7–18 ONLY!